Progress and Promise in Parkinson's

submitted by: CIRMTV

Parkinson's disease is a neurodegenerative disease that affects nearly a million people in the U.S. No cure exists and current medications become less effective over time. This video provides a patient's perspective of living with Parkinson's and a scientist's efforts to better understand the disease using novel stem cell research strategies.

Progress and Promise in Huntington's

submitted by: CIRMTV

Huntington's disease (HD) is a genetic neurodegenerative disorder that typically strikes in a person's thirties and leads to death 10-15 years later. Through firsthand stories, this video describes the devastating impact of the disease on families, the inspirational power of patient advocacy, and the promise of stem cell research to find a cure.

Obama Inauguration: A Positive Change in Federal Stem Cell Research Policies

submitted by: CIRMTV
On March 9, 2009, President Barack Obama signed an executive order to lift a ban on federal funding for embryonic stem cell research that had been in place since August, 2001. In this video, Susan Fisher, director of the UCSF Human Embryonic Stem Cell Center, and Alan Trounson, president of the California Institute for Regenerative Medicine, discuss how the federal ban affected stem cell researchers and how President Obama's stem cell research policies will bring new opportunities in this...

Jerome Zack Talks About Creating iPS Cells

submitted by: CIRMTV
In 2006 scientists learned how to create a pluripotent stem cell out of a human skin cell. These cells, called induced pluripotent stem (iPS) cells have many of the characteristics of embryonic stem cells including the ability to create mature cell types. Dr. Jerome Zack has a CIRM grant to create iPS cells that could be used in human therapies. Zack is Associate Director, UCLA AIDS Institute, professor of Medicine, Microbiology, Immunology & Molecular Genetics, and a scientist with the...

Alan Lewis: Embryonic Stem Cell Therapies for Diabetes

submitted by: CIRMTV

Embryonic stem cells have the potential to help treat 70 or more diseases, but developing those new therapies will take time. Alan Lewis is president and CEO of Novocell, a La Jolla-based company that has been developing a potential therapy for diabetes. Novocell has a CIRM grant to assemble a team of researchers who will accelerate the time it takes to get that potential therapy to the FDA for clinical trials.

Mark Mercola: Differentiating Embryonic Stem Cells into Adult Tissues

submitted by: CIRMTV
A major challenge in developing stem cell-based cures for disease is maturing those cells into adult cell types that can be used for transplantation or to study human disease. Mark Mercola has a CIRM grant to derive heart muscle cells from embryonic stem cells. In this video, Dr. Mercola describes how stem cells could one day be used for transplantation, for testing new drugs for side effects on heart muscle cells, and to learn about how the heart cells mature and develop. That knowledge...